Clinical Trial

A Study of D-2570 in Patients With Active Systemic Lupus Erythematosus (SLE)

Name: A Study of D-2570 in Patients With Active Systemic Lupus Erythematosus (SLE) — clinical trial record (NCT07311200)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Phase 2

View on ClinicalTrials.gov →

Summary

This study is a multicenter, randomized, double-blind, placebo-controlled Phase II clinical trial designed to evaluate the efficacy and safety of D-2570 in the treatment of active systemic lupus erythematosus.

Protocol Amendment History 1 change

critical Recruitment opened 2026-04-25

Trial Details

NCT Number	NCT07311200
Lead Sponsor	InventisBio Co., Ltd
Conditions	Active Systemic Lupus Erythematosus
Enrollment	120 participants
Start Date	2026-02-12
Primary Completion	2028-08-31 (estimated)
Study Completion	2028-12-31 (estimated)
Updated on ClinicalTrials.gov	2026-04-24